These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18088232)

  • 1. Stat5 as a diagnostic marker for leukemia.
    Lewis RS; Ward AC
    Expert Rev Mol Diagn; 2008 Jan; 8(1):73-82. PubMed ID: 18088232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
    Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
    Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Going with the flow: JAK-STAT signaling in JMML.
    Kalaitzidis D; Gilliland DG
    Cancer Cell; 2008 Oct; 14(4):279-80. PubMed ID: 18835028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.
    Fantin VR; Loboda A; Paweletz CP; Hendrickson RC; Pierce JW; Roth JA; Li L; Gooden F; Korenchuk S; Hou XS; Harrington EA; Randolph S; Reilly JF; Ware CM; Kadin ME; Frankel SR; Richon VM
    Cancer Res; 2008 May; 68(10):3785-94. PubMed ID: 18483262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT5 and STAT5 Inhibitors in Hematological Malignancies.
    Tolomeo M; Meli M; Grimaudo S
    Anticancer Agents Med Chem; 2019; 19(17):2036-2046. PubMed ID: 31490767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional interactions between STAT5 and Runx transcription factors.
    Ogawa S; Satake M; Ikuta K
    J Biochem; 2008 May; 143(5):695-709. PubMed ID: 18296717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
    Håkansson P; Nilsson B; Andersson A; Lassen C; Gullberg U; Fioretos T
    Genes Chromosomes Cancer; 2008 Apr; 47(4):267-75. PubMed ID: 18181176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SPS affair: a complex tale of illicit proliferation.
    Braun BS; Shannon K
    Cancer Cell; 2009 Aug; 16(2):87-8. PubMed ID: 19647218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
    Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
    Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.
    Baltayiannis G; Baltayiannis N; Tsianos EV
    J BUON; 2008; 13(2):263-5. PubMed ID: 18555475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the mouse TCRgamma enhancers by STAT5.
    Tani-ichi S; Satake M; Ikuta K
    Int Immunol; 2009 Sep; 21(9):1079-88. PubMed ID: 19651644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
    Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
    Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
    Nishioka C; Ikezoe T; Yang J; Takeuchi S; Koeffler HP; Yokoyama A
    Leuk Res; 2008 Sep; 32(9):1382-92. PubMed ID: 18394702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling networks regulating cardiac myocyte survival and death.
    Wagner M; Siddiqui MA
    Curr Opin Investig Drugs; 2009 Sep; 10(9):928-37. PubMed ID: 19705335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
    Tao W; Wen F; Zhang H; Liu G
    Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNgamma signaling-does it mean JAK-STAT?
    Gough DJ; Levy DE; Johnstone RW; Clarke CJ
    Cytokine Growth Factor Rev; 2008; 19(5-6):383-94. PubMed ID: 18929502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways.
    Lee CL; Sit WH; Jiang PP; So IW; Wan JM
    J Pharm Pharmacol; 2008 Nov; 60(11):1491-9. PubMed ID: 18957170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
    Masson K; Liu T; Khan R; Sun J; Rönnstrand L
    Br J Haematol; 2009 Jul; 146(2):193-202. PubMed ID: 19438505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.